Use of Complementary and Alternative Medicine in Children and Adults With Atopic Dermatitis

NCT05833880 | Completed DMC

• 1 other identifier: 2023-A00605-40
• Study Type: observational
• Target: 89
• Locations: 1 country
• Sites: 1

Brief Summary

Complementary and alternative medicine are increasingly used all around the world and more specifically in chronic diseases such as atopic dermatitis. Sociodemographic and disease determinants associated with their use remain unclear. Moreover, most of studies involved children and little data are available for adults. The main objective of this study is to identify factors associated with complementary and alternative medicine use in children and adults suffering from atopic dermatitis. The secondary objectives are to determine the prevalence of complementary and alternative medicine use, the main forms used and their modalities of use, patients' motivations for using these therapies and sources of information. Patients of all ages consulting for their atopic dermatitis at the dermatology or pediatric allergology department of Nancy University Hospital over a 6 months period will be asked to fill out a questionnaire about their pathology and their use of complementary and alternative medicine. This questionnaire will be collected before they leave the hospital.

Conditions

Atopic Dermatitis

Keywords

Atopic Dermatitis; Atopic Eczema; Complementary and Alternative Medicine

Outcome Measures

Primary Outcomes (1)

• Binary variable: use of complementary and alternative medicine (yes/no)

  Binary variable: use of complementary and alternative medicine (yes/no), variable collected by questionnaire, as reported by the patient (or the patient's parents)

  Baseline (J0)

Secondary Outcomes (5)

• Percentage of patients using complementary and alternative medicine in relation to the total number of patients included in the study

  Baseline (J0)

• Forms of complementary and alternative medicine used

  Baseline (J0)

• Modalities of use of complementary and alternative medicine

  Baseline (J0)

• Patients' motivations for using complementary and alternative medicine

  Baseline (J0)

• Sources of information regarding complementary and alternative medicine

  Baseline (J0)

Study Arms (1)

Atopic dermatitis patients

Behavioral: Self-administered questionnaire

Interventions

Self-administered questionnaire BEHAVIORAL

Self-administered questionnaire regarding complementary and alternative medicine use

Atopic dermatitis patients

Eligibility Criteria

• Sex: all
• Age Groups: Child (0-17), Adult (18-64), Older Adult (65+)
• Sampling Method: Probability Sample

Study Population

Patients of all ages suffering from atopic dermatitis visiting the dermatology or pediatric allergology department of Nancy University Hospital

You may qualify if:

• All patients, adults or children, without age limit;
• Patients visiting the dermatology or pediatric allergology department of Nancy University Hospital;
• Patients with atopic dermatitis confirmed on clinical examination by the physician;
• Patients with a history of atopic dermatitis or newly diagnosed patients;
• Patient affiliated to a social security plan or beneficiary of such a plan;
• Patients who understand French and are able to complete a self-administered questionnaire or have the option of assistance in completing it.

You may not qualify if:

• Patient with at least one other dermatological pathology or non-atopic eczema (contact eczema, ...);
• Patient without a confirmed diagnosis of atopic dermatitis by a physician;
• Patient who has already completed the questionnaire during a previous consultation;
• Pregnant and breastfeeding women;
• Refusal of the patient or at least one of the parents for children;
• Patient placed under court protection, guardianship or curatorship;
• Patient deprived of liberty by a judicial or administrative decision.

Sponsors & Collaborators

• Central Hospital, Nancy, France: lead

Study Sites (1)

University Hospital of Nancy

Nancy, France

Location

MeSH Terms

Conditions

Dermatitis, Atopic

Condition Hierarchy (Ancestors)

Skin Diseases, Genetic; Genetic Diseases, Inborn; Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Dermatitis; Skin Diseases; Skin and Connective Tissue Diseases; Skin Diseases, Eczematous; Hypersensitivity, Immediate; Hypersensitivity; Immune System Diseases

Study Officials

• Anne-Claire Bursztejn

  University Hospital of Nancy, France

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: observational
• Observational Model: CASE ONLY
• Time Perspective: PROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Director, Head of Dermatology, Principal Investigator, Clinical Professor

Study Record Dates

• First Submitted: April 2, 2023
• First Posted: April 27, 2023
• Study Start: May 10, 2023
• Primary Completion: August 3, 2023
• Study Completion: August 3, 2023
• Last Updated: December 1, 2023

Record last verified: 2023-11

Locations

FR (1)